Scienture Holdings (SCNX) Stock Research

Scienture Holdings

· SCNX

Dashboard

Financials

Ratios

Valuation

Statistics

10.668 M

-31.83%

Today

Scienture's Arbli added to formularies at 3 U.S. pediatric academic med centers

SCNX

8:09 AM

Wednesday

Scienture announces reverse stock split

SCNX

Sep 30, 4:07 PM

Over a week ago

Scienture expands commercial reach of Rexenopy to Addiction Treatment Centers

SCNX

Sep 22, 8:23 AM

Scienture announces commercial launch of Rezenopy Nasal Spray

SCNX

Aug 12, 8:11 AM

Scienture to begin shipments of Rezonopy to wholesalers

SCNX

Jul 9, 9:33 AM

Scienture announces progress in commercialization of Arbli

SCNX

Jun 18, 8:29 AM

Scienture reveives U.S. patent covering Rezenopy Nasal Spray

SCNX

Jun 2, 8:54 AM

Scienture announces third patent granted for Arbli

SCNX

May 6, 9:45 AM

Scienture granted 180-day extension to meet Nasdaq minimum bid price

SCNX

Apr 15, 9:29 AM

Scienture formalized multiple GPO agreements for Rezenopy

SCNX

Mar 11, 8:13 AM

Scienture initiated with bullish view at Maxim

SCNX

Feb 24, 8:22 AM

Scienture provides commercial update on Arbli

SCNX

Feb 3, 8:06 AM

Scienture announces USPTO issues patent covering REZENOPY Nasal Spray

SCNX

Jan 14, 8:08 AM

Scienture provides update on commercial launch of REZENOPY

SCNX

Dec 22, 8:12 AM

Scienture, BlinkRx announce strategic collaboration to expand access to Arbli

SCNX

Dec 10, 8:16 AM

Scienture reports Q3 EPS (19c) vs. ($1.34) last year

SCNX

Nov 13, 8:14 AM

Scienture announces addition of Arbli to formularies of national health plans

SCNX

Nov 4, 8:28 AM

Scienture starts commercial sales, fulfillment of first orders of Arbli

SCNX

Oct 23, 8:20 AM

Scienture's Arbli is commercially available through wholesalers nationwide

SCNX

Oct 16, 9:03 AM

Scienture announces repayment, conversion of outstanding debentures

SCNX

Oct 8, 9:13 AM

No more stories

Charts